IGC Pharma (IGC) vs Immutep (IMMP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Immutep (IMMP) has outperformed IGC Pharma (IGC) over the past year, gaining 95.2% versus a loss of 31.7%. Over five years, IMMP leads with a +2.8% price change compared with -80.8% for IGC. Immutep is the larger company by market cap ($29.9 million vs $28.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IGC | IMMP |
|---|---|---|
| Share price | $0.28 | $4.06 |
| Market cap | $28.95M | $29.92M |
| 1-day change | 0.00% | -6.45% |
| YTD return | 0.00% | +41.96% |
| 1-year return | -31.71% | +95.19% |
| 5-year return | -80.82% | +2.78% |
| EPS (TTM) | $-0.07 | $-6.82 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $0.45 | $70.60 |
| 52-week low | $0.24 | $4.04 |
| Distance from 52-week high | -37.78% | -94.25% |
| Average volume | 716.87K | 14.78K |
| Shares outstanding | 103.38M | 7.37M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IMMP has outperformed IGC by 126.9 percentage points over the past year.
IGC vs IMMP FAQ
Which is bigger, IGC Pharma or Immutep?
Immutep (IMMP) is larger, with a market capitalization of $29.92M compared with $28.95M for IGC Pharma (IGC).
Which stock has performed better over the past year, IGC or IMMP?
IMMP returned +95.19% over the past 12 months, compared with -31.71% for IGC (price return, excluding dividends). Past performance does not predict future results.
Are IGC Pharma and Immutep in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.